AR’s high ratio of expression (78%) provides an optimal sensitive and specific index to predict the prognosis of breast cancer, and the ratio of AR : ERα over 0.87 suggests the best outcome in ERα-positive breast cancer (p < 0.0001) (47). This evidence concerns the gene ESR1 and breast carcinoma.